Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 5 | $74,833,729 |
| Sells | 61 | $337,748,479 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 30 Oct 2024 19:30 | JANX | Janux Therapeutics Inc | CAMPBELL DAVID ALAN | President and CEO | 28 Oct 2024 | Sale | 13,897 | 53.2237 | 739,650 | D |
| 30 Oct 2024 19:30 | JANX | Janux Therapeutics Inc | CAMPBELL DAVID ALAN | President and CEO | 28 Oct 2024 | Sale | 11,103 | 53.9412 | 598,909 | D |
| 24 Oct 2024 16:15 | JANX | Janux Therapeutics Inc | LICHTER JAY | 10% | 13 Sep 2024 | Sale | 3,815 | 46.68 | 178,084 | D |
| 22 Oct 2024 16:20 | JANX | Janux Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 18 Oct 2024 | Purchase | 1,200,000 | 44.75 | 53,700,000 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 16 Oct 2024 | Sale | 60,179 | 49.69 | 2,990,295 | D |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 16 Oct 2024 | Sale | 11,657 | 49.69 | 579,236 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 16 Oct 2024 | Sale | 61,445 | 49.69 | 3,053,202 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 16 Oct 2024 | Sale | 29,474 | 50.61 | 1,491,679 | D |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 16 Oct 2024 | Sale | 5,710 | 50.61 | 288,983 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 16 Oct 2024 | Sale | 30,094 | 50.61 | 1,523,057 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 16 Oct 2024 | Sale | 10,957 | 50.8 | 556,616 | D |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 17 Oct 2024 | Sale | 1,843 | 50.02 | 92,187 | D |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 18 Oct 2024 | Sale | 102,732 | 50.3 | 5,167,420 | D |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 18 Oct 2024 | Sale | 19,900 | 50.3 | 1,000,970 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 18 Oct 2024 | Sale | 104,892 | 50.3 | 5,276,068 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 18 Oct 2024 | Sale | 15,462 | 51.18 | 791,345 | D |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 18 Oct 2024 | Sale | 2,995 | 51.18 | 153,284 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 18 Oct 2024 | Sale | 15,788 | 51.18 | 808,030 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 18 Oct 2024 | Sale | 541,824 | 44.75 | 24,246,624 | D |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 18 Oct 2024 | Sale | 104,957 | 44.75 | 4,696,826 | I |
| 18 Oct 2024 18:51 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 18 Oct 2024 | Sale | 553,219 | 44.75 | 24,756,550 | I |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 26 Sep 2024 | Sale | 49,497 | 46.78 | 2,315,470 | D |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 26 Sep 2024 | Sale | 9,592 | 46.78 | 448,714 | I |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 26 Sep 2024 | Sale | 50,539 | 46.78 | 2,364,214 | I |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 26 Sep 2024 | Sale | 40,803 | 47.77 | 1,949,159 | D |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 26 Sep 2024 | Sale | 7,908 | 47.77 | 377,765 | I |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 26 Sep 2024 | Sale | 41,661 | 47.77 | 1,990,146 | I |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 27 Sep 2024 | Sale | 45,894 | 46.42 | 2,130,399 | D |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 27 Sep 2024 | Sale | 8,894 | 46.42 | 412,859 | I |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 27 Sep 2024 | Sale | 46,861 | 46.42 | 2,175,288 | I |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 27 Sep 2024 | Sale | 1,511 | 47.74 | 72,135 | D |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 27 Sep 2024 | Sale | 293 | 47.74 | 13,988 | I |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 27 Sep 2024 | Sale | 1,542 | 47.74 | 73,615 | I |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 27 Sep 2024 | Sale | 1,826 | 46.19 | 84,343 | D |
| 30 Sep 2024 20:49 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 30 Sep 2024 | Sale | 958 | 46.24 | 44,298 | D |
| 27 Sep 2024 19:32 | JANX | Janux Therapeutics Inc | MEYER ANDREW HOLLMAN | Chief Business Officer | 27 Sep 2024 | Sale | 50,000 | 45.9551 | 2,297,755 | D |
| 27 Sep 2024 19:31 | JANX | Janux Therapeutics Inc | DIRAIMONDO THOMAS | Chief Scientific Officer | 27 Sep 2024 | Sale | 675 | 47.2245 | 31,877 | D |
| 27 Sep 2024 19:31 | JANX | Janux Therapeutics Inc | DIRAIMONDO THOMAS | Chief Scientific Officer | 27 Sep 2024 | Sale | 4,325 | 46.2057 | 199,840 | D |
| 27 Sep 2024 19:30 | JANX | Janux Therapeutics Inc | CAMPBELL DAVID ALAN | President and CEO | 27 Sep 2024 | Sale | 795 | 47.8384 | 38,032 | D |
| 27 Sep 2024 19:30 | JANX | Janux Therapeutics Inc | CAMPBELL DAVID ALAN | President and CEO | 27 Sep 2024 | Sale | 5,248 | 46.855 | 245,895 | D |
| 27 Sep 2024 19:30 | JANX | Janux Therapeutics Inc | CAMPBELL DAVID ALAN | President and CEO | 27 Sep 2024 | Sale | 18,957 | 46.0893 | 873,715 | D |
| 12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 12 Sep 2024 | Sale | 161,356 | 47 | 7,583,732 | I |
| 12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 12 Sep 2024 | Sale | 30,613 | 47 | 1,438,811 | I |
| 12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 12 Sep 2024 | Sale | 158,031 | 47 | 7,427,457 | D |
| 12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 6,649 | 46.66 | 310,242 | I |
| 12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 35,047 | 46.66 | 1,635,293 | I |
| 12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 34,326 | 46.66 | 1,601,651 | D |
| 12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 11,557 | 46.13 | 533,124 | I |
| 12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 2,193 | 46.13 | 101,163 | I |
| 12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 11,319 | 46.13 | 522,145 | D |
| 10 Sep 2024 17:02 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 09 Sep 2024 | Sale | 2,182 | 42.33 | 92,364 | D |
| 10 Sep 2024 17:02 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 06 Sep 2024 | Sale | 20,991 | 42 | 881,622 | I |
| 10 Sep 2024 17:02 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 06 Sep 2024 | Sale | 110,644 | 42 | 4,647,048 | I |
| 10 Sep 2024 17:02 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 06 Sep 2024 | Sale | 108,365 | 42 | 4,551,330 | D |
| 05 Jun 2024 19:25 | JANX | Janux Therapeutics Inc | LICHTER JAY | Director , 10% | 03 Jun 2024 | Sale | 691,525 | 54.75 | 37,860,994 | I |
| 05 Jun 2024 19:25 | JANX | Janux Therapeutics Inc | LICHTER JAY | Director , 10% | 03 Jun 2024 | Sale | 131,196 | 54.75 | 7,182,981 | I |
| 05 Jun 2024 19:25 | JANX | Janux Therapeutics Inc | LICHTER JAY | Director , 10% | 03 Jun 2024 | Sale | 677,279 | 54.75 | 37,081,025 | I |
| 05 Jun 2024 19:23 | JANX | Janux Therapeutics Inc | REARDON TIGHE | Acting Chief Financial Officer | 03 Jun 2024 | Sale | 691,525 | 54.75 | 37,860,994 | I |
| 05 Jun 2024 19:23 | JANX | Janux Therapeutics Inc | REARDON TIGHE | Acting Chief Financial Officer | 03 Jun 2024 | Sale | 131,196 | 54.75 | 7,182,981 | I |
| 05 Jun 2024 19:19 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 03 Jun 2024 | Sale | 691,525 | 54.75 | 37,860,994 | I |
| 05 Jun 2024 19:19 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 03 Jun 2024 | Sale | 131,196 | 54.75 | 7,182,981 | I |
| 05 Jun 2024 19:19 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 03 Jun 2024 | Sale | 677,279 | 54.75 | 37,081,025 | D |
| 15 Nov 2023 16:48 | JANX | Janux Therapeutics Inc | REARDON TIGHE | Acting Chief Financial Officer, 10% | 13 Nov 2023 | Purchase | 849,854 | 5.87 | 4,988,643 | I |
| 15 Nov 2023 16:46 | JANX | Janux Therapeutics Inc | LICHTER JAY | Director , 10% | 13 Nov 2023 | Purchase | 849,854 | 5.87 | 4,988,643 | I |
| 13 Nov 2023 19:11 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 13 Nov 2023 | Purchase | 849,854 | 5.87 | 4,988,643 | I |
| 21 Jul 2023 16:31 | JANX | Janux Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 19 Jul 2023 | Purchase | 495,008 | 12.46 | 6,167,800 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)